Align Technology
ALGN
139.87
-1.58
-1.12%
Align Technology
US · ALGN
#1450 by market cap
Listed 1970
139.87
-1.58
-1.12%
Live - 5344 symbols - heartbeat 101s ago
· 2026-10-08 03:59
After-hours
139.87
0.00%
Overnight
139.18
-0.49%
- Market cap
- 9.94B
- P/E (TTM)i
- 24.28
- P/Bi
- 2.35
- EPSi
- 5.65
- Div yieldi
- 0.00%
- 52W posi
- 18%
Reader sentiment
Are you bullish or bearish on ALGN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.37, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +0.90% YoY
Margins
- Gross margin
- 67.19%
- Operating margin
- 14.51%
- Net margin
- 10.17%
Key ratios & quality
- PEG ratioi
- 5.64
- Altman Z-Scorei
- 4.37
PEG uses trailing P/E against the 3-year net income growth rate (4.31%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.97B | 2.41B | 2.47B | 3.95B | 3.73B | 3.86B | 4.00B | 4.03B |
| Gross profit | 1.45B | 1.74B | 1.76B | 2.94B | 2.63B | 2.71B | 2.80B | 2.71B |
| Selling & admin expenses | 852.40M | 1.07B | 1.20B | 1.71B | 1.67B | 1.70B | 1.76B | 1.76B |
| Research & development | 128.90M | 157.36M | 175.31M | 250.32M | 305.26M | 346.83M | 364.20M | 369.91M |
| Operating profit | 466.56M | 514.48M | 387.17M | 976.40M | 654.05M | 656.65M | 671.76M | 585.31M |
| Pretax profit | 466.65M | 562.65M | 378.95M | 1.01B | 599.06M | 641.20M | 608.96M | 585.29M |
| Tax | 57.72M | 112.35M | -1.40B | 240.40M | 237.48M | 196.15M | 187.60M | 174.94M |
| Net profit | 400.24M | 442.78M | 1.78B | 772.02M | 361.57M | 445.05M | 421.36M | 410.35M |
| Basic EPS | 5 | 6 | 23 | 10 | 5 | 6 | 6 | 6 |
| Diluted EPS | 4.92 | 5.53 | 22.41 | 9.69 | 4.61 | 5.81 | 5.62 | 5.65 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 979.26M | 1.01B | 995.69M | 1.05B | 1.04B | 1.06B |
| Gross profit | 680.11M | 708.12M | 639.20M | 683.59M | 736.59M | 757.43M |
| Selling & admin expenses | 447.63M | 448.69M | 417.80M | 441.68M | 465.34M | 462.67M |
| Research & development | 97.20M | 96.40M | 93.28M | 83.04M | 98.66M | 102.03M |
| Operating profit | 135.28M | 163.03M | 128.13M | 158.88M | 172.59M | 192.73M |
| Pretax profit | 140.44M | 173.52M | 94.73M | 176.60M | 148.89M | 148.69M |
| Tax | 47.21M | 48.91M | 37.98M | 40.84M | 36.12M | 40.40M |
| Net profit | 93.23M | 124.61M | 56.75M | 135.76M | 112.77M | 108.29M |
| Basic EPS | 1 | 2 | 1 | 2 | 2 | 2 |
| Diluted EPS | 1.27 | 1.72 | 0.78 | 1.89 | 1.57 | 1.51 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.30B | 1.63B | 1.85B | 2.49B | 2.42B | 2.45B | 2.49B | 2.62B |
| Cash & ST investments | 735.36M | 868.63M | 960.84M | 1.17B | 999.58M | 972.74M | 1.04B | 1.09B |
| Inventory | 55.64M | 112.05M | 139.24M | 230.23M | 338.75M | 296.90M | 254.29M | 226.34M |
| Total assets | 2.05B | 2.50B | 4.83B | 5.94B | 5.95B | 6.08B | 6.21B | 6.23B |
| Total current liabilities | 692.07M | 970.97M | 1.33B | 1.92B | 1.93B | 2.07B | 2.04B | 1.92B |
| Short-term debt | -- | 15.74M | 21.74M | 22.72M | 26.57M | 29.65M | 31.06M | 31.94M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 799,567,000.00 | 1,154,533,000.00 | 1,595,818,000.00 | 2,319,396,000.00 | 2,346,589,000.00 | 2,453,388,000.00 | 2,362,615,000.00 | 2,184,546,000.00 |
| Total equity | 1.25B | 1.35B | 3.23B | 3.62B | 3.60B | 3.63B | 3.85B | 4.05B |
| Retained earnings | 378.14M | 439.91M | 2.22B | 2.62B | 2.57B | 2.45B | 2.48B | 2.46B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.40B | 2.45B | 2.53B | 2.62B | 2.66B | 2.66B |
| Cash & ST investments | 873.01M | 901.16M | 1.00B | 1.09B | 1.06B | 1.10B |
| Inventory | 246.57M | 243.75M | 228.16M | 226.34M | 214.94M | 212.24M |
| Total assets | 6.10B | 6.22B | 6.23B | 6.23B | 6.31B | 6.42B |
| Total current liabilities | 1.99B | 2.00B | 1.97B | 1.92B | 1.91B | 1.91B |
| Short-term debt | 32.05M | 32.55M | 33.99M | 31.94M | 32.62M | 34.22M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 2,308,577,000.00 | 2,306,315,000.00 | 2,276,094,000.00 | 2,184,546,000.00 | 2,164,754,000.00 | 2,185,128,000.00 |
| Total equity | 3.79B | 3.91B | 3.96B | 4.05B | 4.15B | 4.23B |
| Retained earnings | 2.39B | 2.43B | 2.42B | 2.46B | 2.55B | 2.60B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 554.68M | 747.27M | 662.17M | 1.17B | 568.73M | 785.78M | 738.23M | 593.22M |
| Depreciation & amortization | 54.73M | 78.99M | 93.54M | 108.73M | 125.79M | 142.40M | 145.03M | 237.44M |
| Free cash flow | 331.37M | 597.56M | 507.26M | 771.45M | 276.83M | 608.06M | 622.65M | 490.78M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -283.37M | -382.09M | 20.31M | -349.42M | -408.89M | -565.77M | -327.60M | -444.19M |
| Ending cash balance | 637.57M | 551.13M | 961.47M | 1.10B | 942.36M | 938.52M | 1.04B | 1.10B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 52.68M | 128.65M | 188.72M | 223.18M | 151.04M | 192.76M |
| Depreciation & amortization | 39.15M | 40.58M | 55.72M | 102.00M | 56.55M | 40.13M |
| Free cash flow | 27.39M | 107.17M | 168.96M | 187.26M | 120.26M | 157.09M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -187.18M | -96.05M | -63.72M | -97.25M | -19.48M | -66.93M |
| Ending cash balance | 874.07M | 902.34M | 1.01B | 1.10B | 1.06B | 1.10B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 33.31 | 34.07 | 77.55 | 22.52 | 10.01 | 12.31 | 11.26 | 10.39 |
| ROA %i | 20.90 | 19.45 | 48.45 | 14.33 | 6.08 | 7.40 | 6.85 | 6.59 |
| ROIC %i | 32.68 | 31.85 | 75.07 | 21.78 | 9.59 | 11.57 | 10.54 | 9.81 |
| 5-year avg ROE %i | 22.88 | 25.49 | 37.40 | 37.78 | 35.48 | 31.29 | 26.73 | 13.30 |
| EBIT margin %i | 23.73 | 21.38 | 15.66 | 24.70 | 17.51 | 17.00 | 16.80 | 14.51 |
| FCF / sales %i | 16.85 | 24.83 | 20.52 | 19.52 | 7.41 | 15.74 | 15.57 | 12.16 |
| Current ratioi | 1.88 | 1.68 | 1.40 | 1.30 | 1.26 | 1.18 | 1.22 | 1.36 |
| Quick ratioi | 1.76 | 1.53 | 1.22 | 1.12 | 1.04 | 0.98 | 1.02 | 1.17 |
| Debt / assetsi | 0.00 | 2.37 | 1.78 | 2.11 | 2.13 | 2.08 | 1.92 | 1.84 |
| LT debt / equityi | -- | 3.23 | 1.99 | 2.83 | 2.79 | 2.67 | 2.29 | 2.04 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 32.49 | 30.62 | 18.82 | 26.20 | 15.77 | 16.04 | 0.39 | 2.61 |
| Net income CAGR (3Y) %i | 40.59 | 32.65 | 97.25 | 24.48 | -6.53 | -36.95 | -18.28 | 4.31 |
| FCF CAGR (3Y) %i | 21.54 | 49.99 | 27.83 | 32.54 | -22.62 | 6.23 | -6.89 | 21.03 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 10.84 | 11.41 | 9.58 | 10.39 | 10.82 | 10.16 |
| ROA %i | 6.68 | 7.07 | 6.01 | 6.59 | 6.92 | 6.55 |
| ROIC %i | 10.13 | 10.68 | 8.95 | 9.81 | 10.25 | 9.58 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 16.40 | 16.09 | 15.15 | 14.51 | 15.20 | 15.76 |
| FCF / sales %i | 15.84 | 15.93 | 14.23 | 12.16 | 14.25 | 15.31 |
| Current ratioi | 1.21 | 1.23 | 1.29 | 1.36 | 1.39 | 1.40 |
| Quick ratioi | 0.99 | 1.03 | 1.09 | 1.17 | 1.17 | 1.20 |
| Debt / assetsi | 1.94 | 1.98 | 1.95 | 1.84 | 1.84 | 1.88 |
| LT debt / equityi | 2.28 | 2.31 | 2.21 | 2.04 | 2.01 | 2.05 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Clear Aligner is the largest reported line at 82.45% of revenue, across 2 reported segments.
- The next-largest line, Systems and Services, is a distant second at 17.55% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Clear Aligner82.45%
Systems and Services17.55%
Quote time 2026-10-08 03:59:33 · For reference only, not investment advice and not tailored to your situation.